Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Ceftazidime-Avibactam in Bile Fluid – an in-vivo Study
DRKS00023533Phase 2Completed
- Sponsor
- Knappschaft Kliniken Universitätsklinikum Bochum
- Start
- Nov 2020
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ceftazidime + avibactam in bacterial enteric infection and cholangiolitis, sponsored by Knappschaft Kliniken Universitätsklinikum Bochum. Started Nov 2020; status: completed.
02
Drugs
ceftazidime + avibactam
03
Conditions
bacterial enteric infectioncholangiolitis
Beyond the preview
Go deeper on DRKS00023533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00023533.